Quarterly report pursuant to Section 13 or 15(d)

Equity Transactions (Summary Of Common Stock Options Activity) (Details)

v3.20.1
Equity Transactions (Summary Of Common Stock Options Activity) (Details)
3 Months Ended
Mar. 31, 2020
$ / shares
shares
Options  
December 31, 2019 | shares 9,299,900
Granted | shares
Exercised | shares
Expired | shares 150,000
Outstanding, March 31, 2020 | shares 9,149,900
Exercisable, March 31, 2020 | shares 9,149,900
Weighted Average Exercise Price  
December 31, 2019 | $ / shares $ 0.57
Granted | $ / shares
Exercised | $ / shares
Expired | $ / shares 1.00
Outstanding, March 31, 2020 | $ / shares 0.56
Exercisable, March 31, 2020 | $ / shares $ 0.56